Skip to main content
SpringerLink
Log in

Frequency of embryos appropriate for transfer following preimplantation genetic testing for monogenic disease

  • Assisted Reproduction Technologies
  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

Purpose

To identify specific likelihoods that an embryo will be classified as appropriate for transfer after preimplantation genetic testing for detection of a monogenic disorder (PGT-M), with or without preimplantation genetic testing for aneuploidy (PGT-A), separated by inheritance pattern.

Methods

Retrospective chart review of 181 selected PGT-M cycles performed at CooperGenomics in 2018 or 2019. For each cycle, the following main outcome data was collected: the number of embryos classified as affected with monogenic disease, the number detected to be chromosomally abnormal, the number that were recombinant, the number that had no result, and if applicable, the number which were aneuploid.

Results

There were significantly fewer embryos appropriate to consider for transfer when PGT-A was included for autosomal recessive and X-linked disorders. There were also fewer for autosomal dominant disorders, though this was not statistically significant. When PGT-A was not included, 45.8% of autosomal dominant, 69% of autosomal recessive, and 47.8% of X-linked embryos were appropriate to consider for transfer. When PGT-A analysis was included, 29% of autosomal dominant, 41% of autosomal recessive, and 22% of X-linked embryos were appropriate to consider for transfer. 96.8% of women elect to include PGT-A when pursuing PGT-M.

Conclusion

This study resulted in specific likelihoods that an embryo would be found appropriate for clinicians and patients to consider for transfer based on the inheritance pattern of the monogenic disease being tested for and whether aneuploidy analysis was included.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Simpson JL, Kuliev A, Rechitsky S. Overview of preimplantation genetic diagnosis (PGD): historical perspective and future direction [Internet]. Humana Press, New York, NY; 2019 [cited 2019 Feb 26]. p. 23–43. Available from: https://doi.org/10.1007/978-1-4939-8889-1_2

  2. Won SY, Kim H, Lee WS, Kim JW, Shim SH. Pre-implantation genetic diagnosis and pre-implantation genetic screening: two years experience at a single center. Obstet Gynecol Sci [Internet] 2018 [cited 2019 Feb 3];61(1):95. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29372155

  3. Brezina PR, Anchan R, Kearns WG. Preimplantation genetic testing for aneuploidy: what technology should you use and what are the differences? J Assist Reprod Genet [Internet] 2016 [cited 2019 Mar 11];33(7):823–32. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27299602

  4. Zimmerman RS, Eccles J, Jalas C, Treff NR, Scott RT. Molecular testing for preimplantation genetic diagnosis of single gene disorders [Internet]. Humana Press, New York, NY; 2019 [cited 2019 Feb 26]. p. 61–71. Available from: https://doi.org/10.1007/978-1-4939-8889-1_4

  5. Treff NR, Zimmerman RS. Advances in preimplantation genetic testing for monogenic disease and aneuploidy. Annu Rev Genomics Hum Genet [Internet]. 2017;18(1):189–200. https://doi.org/10.1146/annurev-genom-091416-035508.

    Article  CAS  Google Scholar 

  6. Geraedts J. Healthy children without fear: reproductive options for patients or couples carrying inherited diseases. EMBO Rep [Internet] 2017 [cited 2019 Mar 11];18(5):666–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28396574

  7. Masbou AK, Friedenthal JB, McCulloh DH, McCaffrey C, Fino ME, Grifo JA, et al. A comparison of pregnancy outcomes in patients undergoing donor egg single embryo transfers with and without preimplantation genetic testing. Reprod Sci [Internet] 2018 [cited 2019 Mar 11];193371911882047. Available from: https://doi.org/10.1177/1933719118820474

  8. Kim TG, Neblett MF, Shandley LM, Omurtag K, Hipp HS, Kawwass JF. National mosaic embryo transfer practices: a survey. Am J Obstet Gynecol [Internet] 2018 [cited 2019 Mar 11];219(6):602.e1–602.e7. Available from: https://www.sciencedirect.com/science/article/pii/S0002937818308226?via%3Dihub

  9. Fragouli E, Alfarawati S, Spath K, Babariya D, Tarozzi N, Borini A, et al. Analysis of implantation and ongoing pregnancy rates following the transfer of mosaic diploid–aneuploid blastocysts. Hum Genet [Internet]. 2017;136(7):805–19. https://doi.org/10.1007/s00439-017-1797-4.

    Article  CAS  Google Scholar 

  10. Spinella F, Fiorentino F, Biricik A, Bono S, Ruberti A, Cotroneo E, et al. Extent of chromosomal mosaicism influences the clinical outcome of in vitro fertilization treatments. Fertil Steril [Internet] 2018 [cited 2019 Feb 3];109(1):77–83. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29191449

  11. Vaz-de-Macedo C, Harper J. A closer look at expanded carrier screening from a PGD perspective. Hum Reprod [Internet] 2017 [cited 2019 Jun 17];32(10):1951–6. Available from: http://academic.oup.com/humrep/article/32/10/1951/4097721/A-closer-look-at-expanded-carrier-screening-from-a

  12. Kang HJ, Melnick AP, Stewart JD, Xu K, Rosenwaks Z. Preimplantation genetic screening: who benefits? Fertil Steril. 2016;106(3):597–602. https://doi.org/10.1016/j.fertnstert.2016.04.027.

    Article  PubMed  Google Scholar 

  13. Munné S, Kaplan B, Frattarelli JL, Child T, Nakhuda G, Shamma FN, Silverberg K, Kalista T, Handyside AH, Katz-Jaffe M, Wells D, Gordon T, Stock-Myer S, Willman S, STAR Study Group. Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial. Fertil Steril. 2019;112(6):1071-1079.e7. https://doi.org/10.1016/j.fertnstert.2019.07.1346.

    Article  CAS  PubMed  Google Scholar 

  14. Kushnir VA, Darmon SK, Albertini DF, Barad DH, Gleicher N. Effectiveness of in vitro fertilization with preimplantation genetic screening: a reanalysis of United States assisted reproductive technology data 2011–2012. Fertil Steril [Internet] 2016 [cited 2019 Mar 13];106(1):75–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26952783

  15. Murphy LA, Seidler EA, Vaughan DA, Resetkova N, Penzias AS, Toth TL, et al. To test or not to test? A framework for counselling patients on preimplantation genetic testing for aneuploidy (PGT-A). Hum Reprod [Internet] 2019 [cited 2019 Mar 11];34(2):268–75. Available from: https://academic.oup.com/humrep/article/34/2/268/5219186

  16. Practice Committees of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology. Electronic address: ASRM@asrm.org; Practice Committees of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology. The use of preimplantation genetic testing for aneuploidy (PGT-A): a committee opinion. Fertil Steril. 2018 Mar;109(3):429–436. https://doi.org/10.1016/j.fertnstert.2018.01.002

  17. Goldman KN, Nazem T, Berkeley A, Palter S, Grifo JA. Preimplantation genetic diagnosis (PGD) for monogenic disorders: the value of concurrent aneuploidy screening. J Genet Couns [Internet]. 2016;25(6):1327–37. https://doi.org/10.1007/s10897-016-9975-4.

    Article  Google Scholar 

  18. Brezina PR, Kutteh WH, Bailey AP, Ke RW. Preimplantation genetic screening (PGS) is an excellent tool, but not perfect: a guide to counseling patients considering PGS. Fertil Steril [Internet] 2016 [cited 2019 Mar 11];105(1):49–50. Available from: https://www.sciencedirect.com/science/article/pii/S0015028215020063?via%3Dihub

  19. Dahdouh EM, Balayla J, García-Velasco JA. Comprehensive chromosome screening improves embryo selection: a meta-analysis. Fertil Steril [Internet] 2015 [cited 2019 Mar 13];104(6):1503–12. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26385405

  20. Franasiak JM, Forman EJ, Hong KH, Werner MD, Upham KM, Treff NR, et al. The nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screening. Fertil Steril [Internet] 2014 [cited 2019 Mar 13];101(3):656–663.e1. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24355045

  21. Toft CLF, Ingerslev HJ, Kesmodel US, et al. A systematic review on concurrent aneuploidy screening and preimplantation genetic testing for hereditary disorders: what is the prevalence of aneuploidy and is there a clinical effect from aneuploidy screening? Acta Obstet Gynecol Scand. 2020;99:696–706. https://doi.org/10.1111/aogs.13823.

    Article  CAS  PubMed  Google Scholar 

  22. Brezina PR, Kutteh WH. Clinical applications of preimplantation genetic testing. BMJ [Internet] 2015 [cited 2019 Mar 18];350:g7611. Available from: https://www.bmj.com/content/350/bmj.g7611

  23. Viotti M, Victor AR, Barnes FL, Zouves CG, Besser AG, Grifo JA, Cheng EH, Lee MS, Horcajadas JA, Corti L, Fiorentino F, Spinella F, Minasi MG, Greco E, Munné S. Using outcome data from one thousand mosaic embryo transfers to formulate an embryo ranking system for clinical use. Fertil Steril. 2021;115(5):1212–24. https://doi.org/10.1016/j.fertnstert.2020.11.041.

    Article  CAS  PubMed  Google Scholar 

  24. Insogna IG, Lanes A, Dobson L, Ginsburg ES, Racowsky C, Yanushpolsky E. Blastocyst conversion rate and ploidy in patients with structural rearrangements. J Assist Reprod Genet. 2021. https://doi.org/10.1007/s10815-021-02131-2.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Kalfoglou AL, Scott J, Hudson K. PGD patients’ and providers’ attitudes to the use and regulation of preimplantation genetic diagnosis. Reprod Biomed Online [Internet] 2005 [cited 2019 Mar 18];11(4):486–96. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16274615

  26. McGowan ML, Burant CJ, Moran R, Farrell R. Patient education and informed consent for preimplantation genetic diagnosis: health literacy for genetics and assisted reproductive technology. Genet Med [Internet] 2009 [cited 2019 Mar 18];11(9):640–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19652605

  27. Munné S, Alikani M, Ribustello L, Colls P, Martínez-Ortiz PA, McCulloh DH, Referring Physician Group. Euploidy rates in donor egg cycles significantly differ between fertility centers. Hum Reprod. 2017;32(4):743–9. https://doi.org/10.1093/humrep/dex031.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This work was conducted by researcher ES to fulfill Master’s degree requirements for Case Western Reserve University’s Genetic Counseling Training Program in Cleveland, Ohio. The authors would like to thank Kevin Cavanagh, PhD, for his contributions to the statistical analyses performed in this study.

Author information

Authors and Affiliations

  1. Department of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, OH, USA

    Emma Stocker & Rebecca Darrah

  2. CooperGenomics, Livingston, NJ, USA

    Sheila Johal

  3. Center for Human Genetics, University Hospitals Cleveland Medical Center, Cleveland, OH, USA

    Larisa Rippel

  4. Frances Payne Bolton School of Nursing, Case Western Reserve University, Cleveland, OH, USA

    Rebecca Darrah

Authors
  1. Emma Stocker
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sheila Johal
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Larisa Rippel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rebecca Darrah
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Emma Stocker.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Stocker, E., Johal, S., Rippel, L. et al. Frequency of embryos appropriate for transfer following preimplantation genetic testing for monogenic disease. J Assist Reprod Genet 39, 2043–2050 (2022). https://doi.org/10.1007/s10815-022-02571-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10815-022-02571-4

Keywords

Search

Navigation